Leading the Way in Heart Health and Recovery

Transcatheter Aortic Valve Implantation (TAVI)

ONUS Robotic Hospitals, through its esteemed ONUS Heart Institute, offers a comprehensive Transcatheter Aortic Valve Implantation (TAVI) program. This cutting-edge treatment is primarily indicated for patients with severe aortic stenosis (AS) who are considered high-risk or inoperable for traditional surgical aortic valve replacement (SAVR).

What is TAVI?

Transcatheter Aortic Valve Implantation (TAVI) is primarily indicated for patients with severe aortic stenosis (AS) who are considered high-risk or inoperable for traditional surgical aortic valve replacement (SAVR). However, with advancements in technology and experience, TAVI is increasingly being used in intermediate- and low-risk patients as well. The decision to perform TAVI is based on both clinical indications and risk stratification to ensure the best outcomes for the patient.

Indications for TAVI:

An artificial intelligence (AI) algorithm for detailed measurement of aortic dimensions is currently commercially available. The algorithm automatically quantifies aortic diameters at nine anatomic landmark positions. There is growing role of artificial intelligence techniques and algorithms in TAVR procedures, on the following areas:
  • Diagnosis: AI algorithms assist in the accurate diagnosis of severe aortic stenosis, ensuring timely and appropriate treatment.
  • Patient Selection: AI helps in identifying suitable candidates for TAVI, optimizing patient outcomes by selecting those who will benefit most from the procedure.
  • Procedural Planning and Execution: AI enhances the planning and execution phases of TAVR by providing detailed anatomical measurements and predictive analytics, leading to more precise and successful interventions.
  • Post-Procedural Predictions: AI algorithms predict post-procedural morbidity and mortality, aiding in risk assessment and patient management.

Other indications include:

  • Bicuspid aortic valve: In certain high-risk patients with calcific bicuspid valves.
  • Degenerative aortic bioprosthesis (valve-in-valve TAVI): In patients with a failing surgical bioprosthetic valve.
  • Poor surgical candidates: Frail patients or those with significant comorbidities, where the risk of open-heart surgery is too high.

Conditions Treated

TAVI is specifically designed to address severe aortic stenosis, especially in patients who are considered high-risk for open-heart surgery due to factors such as:

  • Advanced age
  • Previous heart surgeries
  • Other underlying health conditions
  • Compromised overall health

By opting for TAVI, patients can benefit from a procedure that offers quicker recovery times, reduced pain, and fewer complications compared to conventional surgical methods.

Benefits of TAVI

  • Less Invasive, Shorter Hospital Stay and Faster Recovery.
  • Lower risk for high surgical risk patients 
  • Lower Incidence of complications 
  • Preservation of Chest anatomy 
  • Reduced Need for General Anesthesia. 
At Onus Heart Institute, we are committed to providing state-of-the-art care for our patients. Our team of highly skilled cardiologists and surgeons utilize the latest technologies and techniques to ensure the best possible outcomes for your heart health.
If you or a loved one is suffering from severe aortic stenosis and are concerned about the risks of traditional surgery, TAVI might be the right solution for you. Contact us today to schedule a consultation and learn more about how TAVI can help restore your heart’s function and enhance your quality of life.

Vision

ONUS Heart Institute’s vision is to revolutionize heart valve care by making minimally invasive, life-saving treatments like TAVI accessible and affordable for every patient.

Mission

– Deliver excellence in cardiovascular care

– Empower patients and communities

– Promote innovation and education

– Drive healthcare equity

Book an Appointment

Please enable JavaScript in your browser to complete this form.